Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.

Parsons N, Annamalai B, Obert E, Schnabolk G, Tomlinson S, Rohrer B.

Mol Immunol. 2019 Apr;108:8-12. doi: 10.1016/j.molimm.2019.02.001. Epub 2019 Feb 12.

PMID:
30763805
2.

Corporate governance data of 6 Asian economies (2010-2017).

Singareddy RRR, Chandrasekaran S, Annamalai B, Ranjan P.

Data Brief. 2018 Jul 27;20:53-56. doi: 10.1016/j.dib.2018.07.048. eCollection 2018 Oct.

3.

Pathology of nNOS-Expressing GABAergic Neurons in Mouse Model of Alzheimer's Disease.

Choi S, Won JS, Carroll SL, Annamalai B, Singh I, Singh AK.

Neuroscience. 2018 Aug 1;384:41-53. doi: 10.1016/j.neuroscience.2018.05.013. Epub 2018 May 19.

PMID:
29782905
4.

Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.

Annamalai B, Parsons N, Belhaj M, Brandon C, Potts J, Rohrer B.

Transl Vis Sci Technol. 2018 Mar 9;7(2):3. doi: 10.1167/tvst.7.2.3. eCollection 2018 Mar.

5.

Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.

Schnabolk G, Parsons N, Obert E, Annamalai B, Nasarre C, Tomlinson S, Lewin AS, Rohrer B.

Mol Ther Methods Clin Dev. 2017 Nov 10;9:1-11. doi: 10.1016/j.omtm.2017.11.003. eCollection 2018 Jun 15.

6.

Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium.

Busch C, Annamalai B, Abdusalamova K, Reichhart N, Huber C, Lin Y, Jo EAH, Zipfel PF, Skerka C, Wildner G, Diedrichs-Möhring M, Rohrer B, Strauß O.

Front Immunol. 2017 Jun 15;8:703. doi: 10.3389/fimmu.2017.00703. eCollection 2017.

7.

Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S.

Neuropharmacology. 2017 Feb;113(Pt A):281-292. doi: 10.1016/j.neuropharm.2016.10.011. Epub 2016 Oct 12.

8.

Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.

Khan M, Dhammu TS, Matsuda F, Annamalai B, Dhindsa TS, Singh I, Singh AK.

Brain Res. 2016 Jan 1;1630:159-70. doi: 10.1016/j.brainres.2015.11.015. Epub 2015 Nov 17.

9.

S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Won JS, Annamalai B, Choi S, Singh I, Singh AK.

Brain Res. 2015 Oct 22;1624:359-369. doi: 10.1016/j.brainres.2015.07.057. Epub 2015 Aug 10.

10.

Akt-mediated regulation of antidepressant-sensitive serotonin transporter function, cell-surface expression and phosphorylation.

Rajamanickam J, Annamalai B, Rahbek-Clemmensen T, Sundaramurthy S, Gether U, Jayanthi LD, Ramamoorthy S.

Biochem J. 2015 May 15;468(1):177-90. doi: 10.1042/BJ20140826.

PMID:
25761794
11.

Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.

Annamalai B, Won JS, Choi S, Singh I, Singh AK.

Biochem Biophys Res Commun. 2015 Feb 27;458(1):214-9. doi: 10.1016/j.bbrc.2015.01.093. Epub 2015 Jan 29.

12.

Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS.

Neuropharmacology. 2014 Nov;86:228-40. doi: 10.1016/j.neuropharm.2014.07.016. Epub 2014 Aug 10.

13.

Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.

Won JS, Kim J, Annamalai B, Shunmugavel A, Singh I, Singh AK.

J Alzheimers Dis. 2013;34(3):621-35. doi: 10.3233/JAD-121786.

14.

Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.

Annamalai B, Mannangatti P, Arapulisamy O, Shippenberg TS, Jayanthi LD, Ramamoorthy S.

Mol Pharmacol. 2012 Jan;81(1):73-85. doi: 10.1124/mol.111.073171. Epub 2011 Oct 12.

15.

Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.

Annamalai B, Mannangatti P, Arapulisamy O, Ramamoorthy S, Jayanthi LD.

J Neurochem. 2010 Oct;115(1):23-35. doi: 10.1111/j.1471-4159.2010.06898.x. Epub 2010 Jul 30.

16.

Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis.

Annamalai B, Liu X, Gopal U, Isaacs JS.

Mol Cancer Res. 2009 Jul;7(7):1021-32. doi: 10.1158/1541-7786.MCR-08-0582. Epub 2009 Jun 30.

17.

Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization.

Jayanthi LD, Annamalai B, Samuvel DJ, Gether U, Ramamoorthy S.

J Biol Chem. 2006 Aug 18;281(33):23326-40. Epub 2006 Jun 1.

Supplemental Content

Loading ...
Support Center